Home/Filings/4/0001144204-17-013286
4//SEC Filing

EYEGATE PHARMACEUTICALS INC 4

Accession 0001144204-17-013286

$KPRXCIK 0001372514operating

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 5:52 PM ET

Size

5.2 KB

Accession

0001144204-17-013286

Insider Transaction Report

Form 4
Period: 2017-03-07
Wirostko Barbara
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2017-03-07$2.83/sh+8,700$24,621217,842 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    41,700

Issuer

EYEGATE PHARMACEUTICALS INC

CIK 0001372514

Entity typeoperating

Related Parties

1
  • filerCIK 0001372514

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 5:52 PM ET
Size
5.2 KB